Prostate News Archive
18-Jan-2009
EPCA-2 testing more accurate way to identify cancer in the prostate (News-Medical-Net)
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year. IMA meet on prostate enlargement (Indian Express via Yahoo! India News)
A clinical meeting was organised on Sunday by the Indian Medical Association on Benign Prostatic Hyperplasia clinical manifestations and management . The meeting was presided over by Dr Diwakar Dalela, the HOD, Urology Department, King George s Medical University (KGMU). Around 20 to 30 doctors from all over the city attended the meting. They later approached Dr Dalela for their queries regarding ... The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With ... (Medical News Today)
UroToday.com- Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh and colleagues in the online version of Cancer.ZA is an intravenous bisphosphonate given to decrease skeletal related events in CaP patients with bone metastases. [click link for full article] GTX Shares Fall on Study Concern (AP via Yahoo! Finance)
Shares of biotechnology company GTX Inc. stumbled Monday on concerns on the risks involved with a late-stage study of the company's prostate cancer drug Acapodene.
Back to Prostate News Archive
